3 completed, 1 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Terminated 1 |
Follow SMOFlipid: new trials by email Literature Review of SMOFlipid trials Research Report on SMOFlipid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lipid Emulsion Infusion and COVID-19 Patients SMOFlipid, 0.9% saline - Covid19 | Phase 3 | Completed | Assiut University | 74 | 2021-07-05 | 2021-09-28 |
| Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates Smoflipid 20% Lipid Emulsion for Injection, Intralipid, 20% Intravenous Emulsion - Cholestasis of Parenteral Nutrition | Phase 3 | Completed | Indiana University | 24 | 2018-11-30 | 2025-07-30 |
| Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants Smoflipid 20% (investigational lipid for parenteral nutrition), Intralipid® 20% - Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days | Phase 3 | Terminated | Fresenius Kabi | 204 | 2015-12-01 | 2022-01-05 |
| A Fatty Acids Study in Preventing Retinopathy of Prematurity SMOFlipid, Clinoleic - Retinopathy of Prematurity | Phase 3 | Completed | Carola Pfeiffer-Mosesson | 90 | 2013-03-01 | 2016-05-03 |
COVID-19 (1) · Hyperphagia (1) · Premature Birth (1) · Retinopathy of Prematurity (1)
Assiut University (1) · Carola Pfeiffer-Mosesson (1) · Fresenius Kabi (1) · Indiana University (1)
United States (2) · Egypt (1)
Carola Pfeiffer-Mosesson, RN (1) · Omar Soliman, MD (1) · Steven A Abrams, MD (1)
PMID 12480795, PMID 29423508, PMID 30297879, PMID 32588218, PMID 33004691, PMID 39374788
2008 (1)